Streetbeat News

Price Targets

INZY

HC Wainwright & Co. has reiterated its Buy rating for Inozyme Pharma (NASDAQ:INZY) and maintained a price target of $14, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 10:51 am

HALO

HC Wainwright & Co. has reiterated its Buy rating for Halozyme Therapeutics, maintaining a price target of $65. This suggests confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 10:32 am

ERAS

HC Wainwright & Co. analyst Andres Maldonado has reiterated a Buy rating on Erasca (NASDAQ:ERAS) and maintained a price target of $6.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 10:28 am

PRME

HC Wainwright & Co. analyst Arthur He has reiterated a Buy rating for Prime Medicine (NASDAQ:PRME) and maintained a $10 price target.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 10:27 am

FURY

HC Wainwright & Co. has maintained a Buy rating on Fury Gold Mines and raised the price target from $1.9 to $2, indicating a positive outlook for the stock.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 10:14 am

SPSC

Needham analyst Scott Berg has reiterated a Buy rating on SPS Commerce (NASDAQ:SPSC) and maintained a price target of $230.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 10:12 am

SSNC

Needham analyst Mayank Tandon has reiterated a Buy rating on SS&C Technologies Holdings (NASDAQ:SSNC) and maintained a price target of $90.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 10:09 am

SAH

Needham analyst Chris Pierce maintains a Buy rating on Sonic Automotive (NYSE:SAH) and raises the price target from $73 to $74.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 9:56 am

COUR

Needham analyst Ryan MacDonald maintains a Buy rating on Coursera (NYSE:COUR) but lowers the price target from $15 to $11.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 9:51 am